Literature DB >> 32901915

Perampanel reduces paroxysmal depolarizing shift and inhibitory synaptic input in excitatory neurons to inhibit epileptic network oscillations.

Ya-Chin Yang1,2,3, Guan-Hsun Wang1,4,5, Ai-Yu Chuang1, Shu-Wei Hsueh2.   

Abstract

BACKGROUND AND
PURPOSE: Perampanel is a newly approved anticonvulsant uniquely targeting AMPA receptors, which mediate the most abundant form of excitatory synaptic transmission in the brain. However, the network mechanism underlying the anti-epileptic effect of the AMPAergic inhibition remains to be explored. EXPERIMENTAL APPROACH: The mechanism of perampanel action was studied with the basolateral amygdala network containing pyramidal-inhibitory neuronal resonators in seizure models of 4-aminopyridine (4-AP) and electrical kindling. KEY
RESULTS: Application of either 4-AP or electrical kindling to the basolateral amygdala readily induces AMPAergic transmission-dependent reverberating activities between pyramidal-inhibitory neuronal resonators, which are chiefly characterized by burst discharges in inhibitory neurons and corresponding recurrent inhibitory postsynaptic potentials in pyramidal neurons. Perampanel reduces post-kindling "paroxysmal depolarizing shift" especially in pyramidal neurons and, counterintuitively, eliminates burst activities in inhibitory neurons and inhibitory synaptic inputs onto excitatory pyramidal neurons to result in prevention of epileptiform discharges and seizure behaviours. Intriguingly, similar effects can be obtained with not only the AMPA receptor antagonist CNQX but also the GABAA receptor antagonist bicuculline, which is usually considered as a proconvulsant. CONCLUSION AND IMPLICATIONS: Ictogenesis depends on the AMPA receptor-dependent recruitment of pyramidal-inhibitory neuronal network oscillations tuned by dynamic glutamatergic and GABAergic transmission. The anticonvulsant effect of perampanel then stems from disruption of the coordinated network activities rather than simply decreased neuronal excitability or excitatory transmission. Positive or negative modulation of epileptic network reverberations may be pro-ictogenic or anti-ictogenic, respectively, constituting a more applicable rationale for the therapy against seizures.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  AMPA receptors; GABAergic transmission; epileptic seizures; glutamatergic transmission; perampanel

Mesh:

Substances:

Year:  2020        PMID: 32901915      PMCID: PMC7589018          DOI: 10.1111/bph.15253

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  101 in total

1.  Physiological and morphological characterization of parvalbumin-containing interneurons of the rat basolateral amygdala.

Authors:  Donald Gordon Rainnie; Irakli Mania; Franco Mascagni; Alexander Joseph McDonald
Journal:  J Comp Neurol       Date:  2006-09-01       Impact factor: 3.215

Review 2.  The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function.

Authors:  R R Llinás
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

3.  Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation.

Authors:  Elodie Picard; Frederic Antonio Carvalho; Francina Agosti; Emmanuel Bourinet; Denis Ardid; Alain Eschalier; Laurence Daulhac; Christophe Mallet
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

4.  Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior.

Authors:  Rita Citraro; Antonio Leo; Valentina Franco; Roberto Marchiselli; Emilio Perucca; Giovambattista De Sarro; Emilio Russo
Journal:  Epilepsia       Date:  2016-12-18       Impact factor: 5.864

5.  Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus.

Authors:  Juliane Redecker; Matthias Wittstock; Reiner Benecke; Johannes Rösche
Journal:  Epilepsy Behav       Date:  2015-03-26       Impact factor: 2.937

Review 6.  "Interneurons and principal cell firing in human limbic areas at focal seizure onset".

Authors:  Shennan A Weiss; Richard Staba; Anatol Bragin; Karen Moxon; Michael Sperling; Massimo Avoli; Jerome Engel
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

7.  Spatiotemporal dynamics of optogenetically induced and spontaneous seizure transitions in primary generalized epilepsy.

Authors:  Fabien B Wagner; Wilson Truccolo; Jing Wang; Arto V Nurmikko
Journal:  J Neurophysiol       Date:  2014-12-30       Impact factor: 2.714

8.  Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.

Authors:  Jacqueline A French; Gregory L Krauss; Victor Biton; David Squillacote; Haichen Yang; Antonio Laurenza; Dinesh Kumar; Michael A Rogawski
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

9.  Temporal lobe epilepsy is a disease of faulty neuronal resonators rather than oscillators, and all seizures are provoked, usually by stress.

Authors:  Arnold E Eggers
Journal:  Med Hypotheses       Date:  2007-05-18       Impact factor: 1.538

10.  Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.

Authors:  Robert C Wykes; Joost H Heeroma; Laura Mantoan; Kaiyu Zheng; Douglas C MacDonald; Karl Deisseroth; Kevan S Hashemi; Matthew C Walker; Stephanie Schorge; Dimitri M Kullmann
Journal:  Sci Transl Med       Date:  2012-11-12       Impact factor: 17.956

View more
  3 in total

1.  Perampanel reduces paroxysmal depolarizing shift and inhibitory synaptic input in excitatory neurons to inhibit epileptic network oscillations.

Authors:  Ya-Chin Yang; Guan-Hsun Wang; Ai-Yu Chuang; Shu-Wei Hsueh
Journal:  Br J Pharmacol       Date:  2020-09-28       Impact factor: 8.739

2.  Successful use of perampanel in GABRA1-related myoclonic epilepsy with photosensitivity.

Authors:  Sara Olivotto; Anna Freddi; Rossella Lavatelli; Eleonora Basso; Alessia Leidi; Barbara Castellotti; Luigina Spaccini; Stefania Maria Bova; Pierangelo Veggiotti
Journal:  Epilepsy Behav Rep       Date:  2022-04-20

Review 3.  An electrophysiological perspective on Parkinson's disease: symptomatic pathogenesis and therapeutic approaches.

Authors:  Lan-Hsin Nancy Lee; Chen-Syuan Huang; Hsiang-Hao Chuang; Hsing-Jung Lai; Cheng-Kai Yang; Ya-Chin Yang; Chung-Chin Kuo
Journal:  J Biomed Sci       Date:  2021-12-09       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.